drugset / Trial / NCT07266233

Toluidine Blue-Based Photodynamic Therapy for Antibacterial Activity and Postoperative Pain

NCT07266233 ↗

Active not recruiting 50 enrolled Ataturk University
RandomizedParallel-groupSingle-blindTreatment

Summary

This clinical study aims to evaluate the antimicrobial effectiveness and postoperative pain outcomes of photodynamic therapy using Toluidine Blue O as an adjunct to conventional root canal treatment in patients diagnosed with symptomatic irreversible pulpitis. Photodynamic therapy is a non-invasive light-activated disinfection method, and this study will compare its performance with standard endodontic treatment protocols. The results are expected to provide clinical evidence regarding its potential benefits in reducing intracanal bacterial load and improving postoperative patient comfort.

Timeline

Start
2025-06-01
Primary completion
2025-11-07
Completion
2026-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Toluidine Blue O Unknown 0.1 mg/ml Other